Friday, Mar 29, 2024 | Last Update : 04:47 PM IST

Keytruda

Study sees immune therapy scoring big win against lung cancer

In the study, Merck's Keytruda, given with standard chemotherapy, cut in half the risk of dying or having the cancer worsen.

17 Apr 2018 9:07 AM

ADVERTISEMENT
ADVERTISEMENT